Market Place
Sourcing Support
All News #Library
Biotech
Leap Jumps From Bio To Crypto After Winding Down Cancer Program
12 Nov 2025 //
FIERCE BIOTECH
Leap Therapeutics Unveils Defiance Study Final Results at ESMO
20 Oct 2025 //
PR NEWSWIRE
Leap Therapeutics Secures $58.88M Investment For Digital Asset
06 Oct 2025 //
PR NEWSWIRE
Leap Therapeutics To Present Defiance Study Part B Data At ESMO
25 Sep 2025 //
PR NEWSWIRE
Leap Therapeutics Reports Second Quarter 2025 Financial Results
14 Aug 2025 //
PR NEWSWIRE
Leap halves head count amid `difficult market environment`
13 May 2025 //
FIERCE BIOTECH
Leap Therapeutics Reports First Quarter 2025 Financial Results
13 May 2025 //
PR NEWSWIRE
Leap Therapeutics to Present FL-501 Preclinical Data at AACR 2025
25 Apr 2025 //
PR NEWSWIRE
Leap Therapeutics Reports Q4 & 2024 Financial Results
26 Mar 2025 //
PR NEWSWIRE
Leap crashes as midphase data mark end of gastric cancer program
29 Jan 2025 //
PR NEWSWIRE
Leap Therapeutics Reports Q3 2024 Financial Results
13 Nov 2024 //
PR NEWSWIRE
Leap Therapeutics Announces Initiation of Part B of the DeFianCe Study of DKN-01
12 Jul 2023 //
PR NEWSWIRE
Leap Announces Completion of Enrollment in Part A of DeFianCe Study of DKN-01
12 Apr 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.